Company / Current Liabilities
Johnson & Johnson Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$54.1B
FY2025
5-year range
$45.2B / $55.8B
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
#1 of 213
Health Care
What the data says
Among 213 Health Care companies, Johnson & Johnson is in the bottom 0% for current liabilities. Increased from $46.3B to $54.1B over the past 2 years.
Based on SEC 10-K filings.
$54.1B in FY2025 with a 5-year CAGR of +5.0%. Ranks 1st among 213 companies in Health Care.
Increased from $46.3B to $54.1B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 213This company $54.1B Sector average $1.6B
▼
+3308.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.0%, indicating consistent growth.
- In FY2025, current liabilities increased 7.6% year-over-year.
- Ranks #1 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.1B | +7.6% |
| FY2024 | $50.3B | +8.7% |
| FY2023 | $46.3B | -17.1% |
| FY2022 | $55.8B | +23.4% |
| FY2021 | $45.2B | +6.4% |
| FY2020 | $42.5B | +18.2% |
| FY2019 | $36.0B | +15.2% |
| FY2018 | $31.2B | +2.3% |
| FY2017 | $30.5B | +16.2% |
| FY2016 | $26.3B | -5.3% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026